We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+10.51%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.21B
AUM Growth
+$355M
Cap. Flow
+$316M
Cap. Flow %
26.21%
Top 10 Hldgs %
40.06%
Holding
747
New
182
Increased
169
Reduced
181
Closed
163

Sector Composition

Rank Sector Weight
1 Healthcare 36.03%
2 Financials 28.77%
3 Technology 9.99%
4 Energy 5.75%
5 Consumer Discretionary 4.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMBI.WS
251
DELISTED
Ambipar Emergency Response Warrants
AMBI.WS
$77.1K 0.01%
+154,260
New +$59K
ARIZR
252
DELISTED
Arisz Acquisition Corp. Right
ARIZR
$76.9K 0.01%
+953,584
New +$104K
PSQH.WS icon
253
PSQ Holdings, Inc. Warrants, Each whole warrant exercisable for 1/15th of a share of Class A common stock at an exercise price of $172.50 per share
PSQH.WS
$75.8K 0.01%
98,761
-275,728
-74% -$93.9K
SKIL.WS
254
DELISTED
Skillsoft Corp. Warrants, each whole warrant is exercisable for 1/20th of a share of Class A Common Stock at an exercise price of $230.00
SKIL.WS
$74.6K 0.01%
1,357,220
+812,971
+149% +$90.6K
TALK icon
255
Talkspace
TALK
$867M
$72.8K 0.01%
+57,353
New +$55.7K
AEON icon
256
AEON Biopharma
AEON
$13.5M
$70.8K 0.01%
+139
New +$97.6K
BIOSW
257
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
$67.9K 0.01%
460,987
+321,287
+230% +$33.3K
DNA.WS
258
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$67.6K 0.01%
257,717
+67,099
+35% +$13.1K
GCTS.WS
259
GCT Semiconductor Holding Warrants
GCTS.WS
$18.7M
$66.1K 0.01%
3,307,227
+397,011
+14% +$46K
BLEUR
260
DELISTED
bleuacacia ltd Rights
BLEUR
$65.8K 0.01%
764,616
+319,718
+72% +$18.1K
GENQW
261
DELISTED
Genesis Unicorn Capital Corp. Warrants
GENQW
$65.3K 0.01%
821,208
-178,792
-18% -$15.1K
MSAIW icon
262
MultiSensor AI Holdings Warrant
MSAIW
$65.1K 0.01%
1,623,863
-124,502
-7% -$4.15K
SLAMW
263
DELISTED
Slam Corp. warrant
SLAMW
$62K 0.01%
326,262
+62,304
+24% +$11.6K
ADVWW
264
DELISTED
Advantage Solutions Warrant
ADVWW
$61.3K 0.01%
471,566
+23,265
+5% +$2.23K
EFHTR
265
DELISTED
EF Hutton Acquisition Corporation I Rights
EFHTR
$61.2K 0.01%
479,648
+419,206
+694% +$60.8K
OTMOW
266
DELISTED
Otonomo Technologies Ltd. Warrant
OTMOW
$60.8K 0.01%
3,041,622
+5,600
+0.2% +$151
IVCPW
267
DELISTED
Swiftmerge Acquisition Corp. Warrants
IVCPW
$54.2K ﹤0.01%
+517,211
New +$52K
EONR.WS
268
EON Resources Warrants
EONR.WS
$51.3K ﹤0.01%
539,766
+501
+0.1% +$53
JGGCR
269
DELISTED
Jaguar Global Growth Corporation I Right
JGGCR
$51.2K ﹤0.01%
341,271
-156,068
-31% -$22K
PL icon
270
Planet Labs
PL
$8.4B
$50.7K ﹤0.01%
15,749
FOA icon
271
Finance of America Companies
FOA
$196M
$47.8K ﹤0.01%
2,500
-360
-13% -$6.04K
HWELW
272
DELISTED
Healthwell Acquisition Corp. I Warrant
HWELW
$44.9K ﹤0.01%
+195,210
New +$30.5K
GFGDR
273
DELISTED
The Growth for Good Acquisition Corporation Right
GFGDR
$39.7K ﹤0.01%
283,365
-292,927
-51% -$44.4K
BWACW
274
DELISTED
BETTER WORLD ACQUISITION CORP. Warrants
BWACW
$38.5K ﹤0.01%
2,408,707
+144,827
+6% +$9.6K
SATX.WS.A
275
DELISTED
SatixFy Communications Ltd.
SATX.WS.A
$37.7K ﹤0.01%
419,167
+10,533
+3% +$936

Similar funds

Cowen and Company's Q2 2023 Portfolio in Review

As of Q2 2023, Cowen and Company held 747 positions worth $1.21B, up 42% from $851M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Cowen and Company deployed $316M of net new capital in Q2 2023, opening 182 new positions and adding to 169 existing holdings. Its largest new stake was NVIDIA: 1,927,500 shares worth $81.5M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 38% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Avadel Pharmaceuticals, an estimated $13.9M trimmed.

  • Cowen and Company's largest Q2 2023 buy was NVIDIA: 1,927,500 shares worth $81.5M.
  • Cowen and Company added most to Ares Acquisition Corporation in Q2 2023, an estimated $15.9M increase.
  • Cowen and Company's biggest Q2 2023 reduction was Avadel Pharmaceuticals, cutting an estimated $13.9M.
  • Cowen and Company fully exited Sylvamo in Q2 2023, selling an estimated $99.5M.
  • Cowen and Company's ten largest holdings make up 40% of its $1.21B portfolio in Q2 2023.
  • Cowen and Company opened 182 new positions and closed 163 in Q2 2023.
  • Cowen and Company's portfolio value rose 42% quarter-over-quarter to $1.21B.

Based on Cowen and Company's 13F filing for Q2 2023, filed 7 Aug 2023.